Literature DB >> 17306660

Maternal decision to terminate pregnancy in case of Down syndrome.

Marijke J Korenromp1, Godelieve C M L Page-Christiaens, Jan van den Bout, Eduard J H Mulder, Gerard H A Visser.   

Abstract

OBJECTIVE: This study explores decisional processes regarding termination of pregnancy because of Down syndrome and aims to identify possibilities for improving counseling. STUDY
DESIGN: Seventy-one women completed questionnaires 4 months after termination of pregnancy for Down syndrome, including motivations for the decision, reasons for doubt, perceived influence and/or pressure at decision-making, and satisfaction with the received health care.
RESULTS: Child-related motivations to the termination were the most frequently mentioned, but almost all women indicated also motives of self-interest. Twenty-one percent of women reported much doubt. Perceived influence of the medical staff was substantial, but most women felt that they had not been put under pressure. Satisfaction with the caregivers was high.
CONCLUSION: Women acknowledge that self-interested motives play an important role. Medical caregivers are among the most important persons for women who decide to terminate pregnancy because of Down syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17306660     DOI: 10.1016/j.ajog.2006.09.013

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities.

Authors:  Anne Hawkins; Ana Stenzel; Joanne Taylor; Valerie Y Chock; Louanne Hudgins
Journal:  J Genet Couns       Date:  2012-09-23       Impact factor: 2.537

2.  Should you edit your children's genes?

Authors:  Erika Check Hayden
Journal:  Nature       Date:  2016-02-25       Impact factor: 49.962

3.  Having a son or daughter with Down syndrome: perspectives from mothers and fathers.

Authors:  Brian G Skotko; Susan P Levine; Richard Goldstein
Journal:  Am J Med Genet A       Date:  2011-09-13       Impact factor: 2.802

4.  Having a brother or sister with Down syndrome: perspectives from siblings.

Authors:  Brian G Skotko; Susan P Levine; Richard Goldstein
Journal:  Am J Med Genet A       Date:  2011-09-09       Impact factor: 2.802

5.  A Qualitative Study of Factors Influencing Decision-Making after Prenatal Diagnosis of down Syndrome.

Authors:  Amy R Reed; Kathryn L Berrier
Journal:  J Genet Couns       Date:  2016-12-29       Impact factor: 2.537

6.  Women's knowledge, attitudes, and beliefs about Down syndrome: a qualitative research study.

Authors:  Denise M Levis; Shelly Harris; Nedra Whitehead; Rebecca Moultrie; Kara Duwe; Sonja A Rasmussen
Journal:  Am J Med Genet A       Date:  2012-04-27       Impact factor: 2.802

7.  Non-invasive prenatal testing (NIPT) and pregnant women's views on good motherhood: a qualitative study.

Authors:  Elisa Garcia; Lidewij Henneman; Janneke T Gitsels-van der Wal; Linda Martin; Isabel Koopmanschap; Mireille N Bekker; Danielle R M Timmermans
Journal:  Eur J Hum Genet       Date:  2021-08-17       Impact factor: 5.351

8.  Imagined futures: how experiential knowledge of disability affects parents' decision making about fetal abnormality.

Authors:  Emma F France; Louise Locock; Kate Hunt; Sue Ziebland; Kate Field; Sally Wyke
Journal:  Health Expect       Date:  2011-05-30       Impact factor: 3.377

Review 9.  The Psychological Challenges of Replacing Conventional Karyotyping with Genomic SNP Array Analysis in Prenatal Testing.

Authors:  Sam Riedijk; Karin E M Diderich; Sanne L van der Steen; Lutgarde C P Govaerts; Marieke Joosten; Maarten F C M Knapen; Femke A T de Vries; Diane van Opstal; Aad Tibben; Robert-Jan H Galjaard
Journal:  J Clin Med       Date:  2014-07-03       Impact factor: 4.241

10.  Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013.

Authors:  Maurike D de Groot-van der Mooren; Saskia Tamminga; Dick Oepkes; Michel E Weijerman; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.